Arca
Skip to content

Warning Letter to RadLogics, Inc.

Unspecified. See RadLogics, Inc.'s company page or this site's inspections.

On Apr 5, 2018, FDA's CDRH sent RadLogics, Inc. a warning letter citing 510(k) required.

  • Letter date: Apr 5, 2018
  • Issued by: CDRH
  • Closeout: —

The Letter

As posted on FDA.gov ↗; cited 21 CFR sections link to their page.

• “Detailed, accurate findings for each case are available in a matter of minutes. By the time you sit down to review a case, the preliminary findings are up on the screen. Instead of spending the majority of your time on detection and characterization, you can focus on the critical task of diagnostics and completing your report.”

• “The RADLogics Virtual Resident is like having a top resident preparing detailed detection and characterization findings for your review.”

• “The RADLogics Virtual Resident is not subject to human variability, minimizing the chances of errors and inconsistencies. For example, if a clinician fails to note that contrast media was used in a scan, this will not affect the accuracy of the findings. The RADLogics Virtual Resident analyzes the images and identifies, independently, whether or not a contrast media was used. The software also scans for all of the disease states that are in each scan module. In the case of Chest CT, for example, even if a referring physician has asked the radiologist to look for a rib fracture, the software will identify lung nodules, if present.”

Recent Letters Citing 510(k) required

See them all

Record

Recipient
—
FDA site ID (FEI)
3012236091

Tags are assigned by Arca from the letter's text. A closeout letter means FDA found the firm's corrections adequate; no closeout does not mean the issues are unresolved. FDA warning letters

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.